These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7300762)

  • 1. Effect of prazosin on renal function in chronic congestive cardiac failure.
    Myers JB; Morgan TO; Walker JN
    Med J Aust; 1981 Sep; 2(6):290-1. PubMed ID: 7300762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamic effect of prazosin in congestive cardiac insufficiency of acute degree].
    López-Sendón J; Coma Canella I; Lombera F; Martin Jadraque L
    Rev Esp Cardiol; 1979; 32(3):253-9. PubMed ID: 493628
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of prazosin on renal function in congestive heart failure.
    Pierpont GL; Franciosa JA; Cohn JN
    Clin Pharmacol Ther; 1980 Sep; 28(3):335-9. PubMed ID: 7408392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
    Aronow WS; Danahy DT
    Am J Med; 1978 Jul; 65(1):155-60. PubMed ID: 356598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prazosin and congestive heart failure: short- and long-term therapy.
    Rouleau JL; Warnica JW; Burgess JH
    Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of vasodilators in congestive cardiac insufficiency: studies with prazosin].
    Conti CR; Miles D; Mehta J
    Cardiology; 1980; 66 Suppl 2():186-92. PubMed ID: 7285029
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term maintenance therapy with prazosin in congestive heart failure.
    Mehta J; Miles D; Iacona M; Conti CR
    Clin Cardiol; 1981 May; 4(3):139-45. PubMed ID: 6790215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K; Rubin SA; Ports TA; Parmley WW
    Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure.
    Franciosa JA
    Prog Cardiovasc Dis; 1982; 24(4):319-30. PubMed ID: 7034048
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O; Burkart F; Bühler FR
    Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    Awan NA; Lee G; DeMaria AN; Mason DT
    Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator therapy in congestive heart failure.
    Mason DT
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):36-42. PubMed ID: 7344600
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial hemodynamic studies during the treatment of congestive heart failure with isolated low-dose oral prazosin therapy.
    Reyns PR; Romney D; Desser KB; Benchimol A
    Angiology; 1979 Dec; 30(12):850-5. PubMed ID: 533015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
    Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
    [No Abstract]   [Full Text] [Related]  

  • 17. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
    Stanaszek WF; Kellerman D; Brogden RN; Romankiewicz JA
    Drugs; 1983 Apr; 25(4):339-84. PubMed ID: 6303744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of low dose prazosin in patients with congestive heart failure.
    Lang CC; Choy AM; Rahman AR; Struthers AD
    Eur Heart J; 1993 Sep; 14(9):1245-52. PubMed ID: 8223740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of vasodilator treatment of chronic circulatory insufficiency on various polycardiographic parameters].
    Guzińska B; Nartowicz E
    Kardiol Pol; 1983; 26(7):565-70. PubMed ID: 6645153
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
    Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.